Serzone has been linked to 26 deaths due to liver damage. Bristol-Myers Squibb, the manufacturer of Serzone - an antidepressenat drug, removed this drug from the market in all European countries on January 8, 2003.

Prior to that, in December 2001, the Food and Drug Administration (FDA) had notified Bristol-Myers Squibb that it must include a "black-box" warning on Serzone packaging. The warning was to advise patients that life-threatening cases of liver failure had been reported in those treated with Serzone. The FDA considers a "black-box" warning the most serious they issue.

Side effects and symptoms of liver dysfunction from taking Serzone include:

• Jaundice 
• Dark colored urine 
• Loss of appetite 
• Yellowing of the white of the eyes 
• Nausea· Abdominal pain 
• Physical discomfort or uneasiness

In the United States, the reported rate of liver failure resulting in death or transplant is one patient in 250,000 to 300,000 for those being treated with Serzone. The FDA has stated that there is no way to predict who may develop liver failure from using this dangerous drug.

At Brown & Crouppen, our experienced team of Serzone and defective drug lawyers provide tough, aggressive representation for Serzone victims and their families.

If you or a loved one has taken Serzone and subsequently suffered any of the symptoms listed above, please call Brown & Crouppen at 1-800-536-HELP for your free legal consultation or save time with our online Contact Form.

Call Brown & Crouppen at 1-800-536-HELP for your free legal consultation or save time with our online Contact Form.

1-800-536-HELP